Stay updated on Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.

Latest updates to the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed study objectives and inclusion criteria for a clinical trial, while adding new identifiers and collaborators related to the study.SummaryDifference43%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
Stay in the know with updates to Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.